ISS National Lab Joins NASA and Industry Partners at Nasdaq
KENNEDY SPACE CENTER (FL), June 7, 2019 – Leadership from the International Space Station (ISS) U.S. National Laboratory joined NASA…
ISS360: The ISS National Lab Blog
Studying Plants in Space: Discussing Space-Based Plant Research at the Indoor AgTech Innovation Summit
At the Indoor AgTech Innovation Summit in New York City tomorrow, International Space Station (ISS) U.S. National Laboratory Commercial Innovation Program Manager Dr. Miki…
Accelerating Our Future in Space: 2019 ISS Research and Development Conference
Join the International Space Station (ISS) U.S. National Laboratory at the 8th annual ISS Research and Development Conference (ISSRDC), July 29 to August 1,…
Examining Nanoparticle Formation in Microgravity for Improved Therapeutic Cancer Vaccines
Pharmaceutical company AstraZeneca is going to space to try to address one of the biggest health challenges on Earth: Cancer. The health and economic…
Supercomputing in Space: HPE’s Spaceborne Computer Returns After a Successful 1.5-Year Mission on the ISS National Lab
After spending 615 days onboard the International Space Station (ISS) U.S. National Laboratory—orbiting the Earth more than 8,900 times and traveling almost 229 million…
Communicating the Value of Space-based R&D at the BIO International Convention
Tomorrow at the BIO International Convention, International Space Station (ISS) U.S. National Laboratory Deputy Chief Scientist…
Spurring Innovation Through Diverse Partnerships: A Report From the 2019 Front End of Innovation Conference
Over its 17-year history, the FEI Conference has developed into a program focused on technological innovation…
Student Researchers Study Crystal Growth on the Space Station
A group of Wisconsin students took their studies of crystal growth out of this world—to the…
ISS National Lab Research Overview, SpaceX CRS-17
The International Space Station U.S. National Laboratory is sponsoring an array of research projects that will launch onboard SpaceX’s Dragon spacecraft.
M.I.T. Osteoarthritis Tissue Chips to the International Space Station
There are no disease-modifying drugs for any type of osteoarthritis on Earth other than painkillers, which do not halt the progression of disease. These investigations on the ISS National Lab may halt the progression of the disease before it becomes irreversible.
Emulate Tissue Chip Research on the International Space Station
Emulate is an innovative and emerging biotechnology company sending a tissue chip investigation to the International Space Station U.S. National Laboratory. Learn about tissue chip technology, and how the microgravity environment of the space station can influence science to benefit patient care on Earth.